Animals bearing xenograft tumors derived from Trx1- or TrxR1-depleted cells showed a significant decrease in tumor size and tumor weight following CHK1i treatment (Fig. 2e, f), leading to significant inhibition of tumor growth (Fig. 2g). This evidence concerns the gene TXNRD1 and neoplasm.